Integration of the 5G-based Remote Healthcare System in Critical Care (IT5GRHSCI)

Integration of the 5G-based Remote Healthcare System in Critical Care: A Comprehensive Report With Multiple Satellite Sites

The primary objective of this initial report is to address the following questions: Under what circumstances do clinical teams at satellite locations utilize the 5G RHS? Does the implementation of 5G RHS result in significant clinical enhancements? Furthermore, additional analyses will be conducted to assess specific improvements in various use cases (e.g., emergency room, diagnosis, treatment, task guidance, and medical education) and to examine whether factors such as the expertise of central physicians, patient and physician locations, and the timing of calls influence clinical outcomes.

Study Overview

• Status: Completed
• Conditions: Telemedicine; Emergency Medicine; Augmented Reality
• Intervention / Treatment: Behavioral: The 5G RHS group receiving audio-video conferencing and effective data management for decision-making via augmented reality platform RealHealthcare System.

Detailed Description

Background: Augmented Reality (AR) has undergone rapid development in recent years, gaining prominence in healthcare, especially when coupled with 5G internet technology. This study delves into the integration of 5G Augmented Reality in emergency medicine, with a focus on its impact on clinical outcomes.

Methods: This study will utilize the 5G-based Remote Healthcare System (5G RHS) to connect four satellite Emergency Room (ER) teams with central experts to assess its effectiveness in critical cases. Data will be collected from July 2022 to June 2023 to address key research questions, including the circumstances prompting the use of 5G RHS, the extent of clinical improvement achieved, and the influence of central physician expertise, patient and physician locations, and calling time on clinical outcomes.

• Study Type: Observational
• Enrollment (Actual): 220

Contacts and Locations

Study Locations

• China
  • Zhejiang
    • Hangzhou, Zhejiang, China, 310012
      • Sir Run Run Shaw Hospital Zhejiang University School of Medicine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

In this study, patients with acute chest pain, stroke and trauma will be enrolled in the departments of emergency medicine in the relevant medical community, Branches of Run Run Shaw Hospital, Zhejiang University School of Medicine.

Description

Inclusion Criteria:

• 1) Age range (≥18 years old).
• 2) Patients with acute chest pain, stroke and trauma were diagnosed in the departments of emergency medicine of the relevant medical community, Branches of Run Run Shaw Hospital, Zhejiang University School of Medicine.
• 3) Voluntarily participate in the study and sign the informed consent; If the subject does not have the ability to understand or sign the informed consent, his/her guardian will represent him/her in the informed process and agree to participate in the study; If illiterate, his/her will need a witness to witness the knowledge process and his/her will decide to participate in the study.

Exclusion Criteria:

• 1) Incomplete clinical data.
• 2) Minors.
• 3) Pregnant women.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

5G RHS group; For all patients receiving care through the 5G-based Remote Healthcare System (5G RHS) teleconsultation platform during the specified time period

Behavioral: The 5G RHS group receiving audio-video conferencing and effective data management for decision-making via augmented reality platform RealHealthcare System.; The 5G RHS group will receive audio-video conferencing and effective data management for decision-making via augmented reality platform. A total of 14 physicians from SRRSH will be participated in the study, offering remote consultations and instant guidance to the physician.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
critical conditions	For all patients receiving care through the 5G RHS platform during the specified time period, we gathered clinical data from electronic health records (EHRs). This data encompasses information related to critical conditions.	from July 2022 to June 2023
background situation	For all patients receiving care through the 5G RHS platform during the specified time period, we will gather clinical data from electronic health records (EHRs). This data encompasses information related to the emergency situation,	from July 2022 to June 2023
reasons for consultation	For all patients receiving care through the 5G RHS platform during the specified time period, we will gather clinical data from electronic health records (EHRs). This data encompasses information related to reasons for seeking remote consultation (including complex challenges, new medical scenarios, and educational interactions).	from July 2022 to June 2023
treatment outcomes	For all patients receiving care through the 5G RHS platform during the specified time period, we will gather clinical data from electronic health records (EHRs). This data encompasses information related to treatment outcomes.	from July 2022 to June 2023

Collaborators and Investigators

• Sponsor: Sir Run Run Shaw Hospital
• Investigators: Study Director: Yecheng Jin, M.D, Sir Run Run Shaw Hospital

Study record dates

Study Major Dates

• Study Start (Actual): July 1, 2022
• Primary Completion (Actual): June 30, 2023
• Study Completion (Actual): August 1, 2023

Study Registration Dates

• First Submitted: June 25, 2024
• First Submitted That Met QC Criteria: July 2, 2024
• First Posted (Actual): July 3, 2024

Study Record Updates

• Last Update Posted (Actual): July 3, 2024
• Last Update Submitted That Met QC Criteria: July 2, 2024
• Last Verified: July 1, 2024

More Information

Terms related to this study

• Keywords: Emergency; Augmented Reality; Mentoring; Patient outcome; Teleconference
• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies
• Other Study ID Numbers: ky20220304-31; 2023YFC3603100 (Other Grant/Funding Number: National Key Research and Development Program of China)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: The data are not publicly available due to their containing information that could compromise the privacy of research participants.; Data cannot be shared openly but are available on request from authors for some reasonable conditions.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No